[1] |
Xu-guang CHEN, Sheng-yi SHI, Lan HU, Yu CHEN, Yi-ming LU, Jing YE.
Evaluative value of plasma fibrin degradation product in early prognosis of patients with hemorrhagic stroke
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 612-616.
|
[2] |
Jia-ling ZHANG, Feng-chun ZHANG, Ying-chun XU.
Research progress in the systemic treatment for breast cancer with brain metastasis
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 671-677.
|
[3] |
Xiao-jun ZHAO, Zhi-gang QIAO, Ting-yu LIANG, Yan-ling AN.
Expression of breast cancer susceptibility gene 1 protein in brain gliomas and its influence on the sensitivity of temozolomide
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 118-122.
|
[4] |
CHEN Si, LIU Chun-liang, ZHAO Qian, SUN Hai-peng, LIU Yun-xia.
Identification of hub genes and key pathways in breast cancersurvival-based bioinformatics analysis
[J]. , 2020, 40(3): 294-.
|
[5] |
YE Xin, ZHOU Xiao-yun, YANG Li, WANG Jie, HE Qi.
Analysis of clinicopathological features and prognosis of young patients with breast cancer in different age groups
[J]. , 2020, 40(3): 351-.
|
[6] |
CHENG Long, XU Wu-qin, ZHANG Peng, HUANG Jian-jun, LI Xiao-ning.
Effect of miR-27a down-regulation on proliferation, migration and invasion in triple-negative breast cancer cells
[J]. , 2020, 40(2): 188-.
|
[7] |
ZHANG Feng-chun, ZHANG Shuo-yuan, CHEN Tian-en, XU Ying-chun.
Clinical application of PD-1/PD-L1 to prognosis prediction and treatment of triple-negative breast cancer
[J]. , 2020, 40(1): 128-.
|
[8] |
HE Qin, ZHANG Wei-bin, SHEN Yu-hui.
Establishment of a prognostic scoring model for the breast cancer patients with spinal metastasis
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(09): 1243-1248.
|
[9] |
LIU Jie, QIU Xiao-chun.
Research hotspots and trends of breast cancer stem cells
[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(07): 881-888.
|
[10] |
LU Yu-jie, JIN Ze-yu, LI Ya-fen, SHEN Kun-wei, CHEN Wei-guo, CHEN Xiao-song.
Receptor status testing and its influence on following treatment selection in breast cancer patients with loco-regional recurrence
[J]. , 2019, 39(9): 1071-.
|
[11] |
GU Xiao-ping1, CHEN Meng-ping1, LIANG A-juan2, LIU Yun-xia1, SUN Hai-peng1, HUANG Ying1.
Regulation of mitochondrial carrier SLC25A13 on breast cancer cell cycle in vitro
[J]. , 2019, 39(8): 848-.
|
[12] |
SUN Xiao-yin, ZHUANG Zhi-gang, FU Yun, CHENG Xiao-lin.
Analysis of X-ray signs and postoperative pathological features of breast cancer
[J]. , 2019, 39(4): 398-.
|
[13] |
DONG Xiao-jing1, ZHANG Nan1, GAN Lu1, WU Yi-ying1, CHEN Yun-yun1, FANG Qiong2.
Compliance analysis of adjuvant therapy in elderly patients with breast cancer under case-management model
[J]. , 2019, 39(2): 170-.
|
[14] |
WANG Zhi-wei, WANG Jie, WEI Min, YANG Li, SHAO Yu-guo, JI Min, HE Qi.
Comparison of therapeutic effects between different cycles of docetaxel, epirubicin and cyclophosphamide regime on adjuvant chemotherapy of locally advanced breast cancer
[J]. , 2019, 39(12): 1432-.
|
[15] |
FANG Qiong1, CHEN Yun-yun1, DONG Xiao-jing1, ZHAGN Nan1, SHEN Kun-Wei1, WU Bei-wen2.
Impact of body weight and physical activity on quality of life among breast cancer patients receiving adjuvant chemotherapy
[J]. , 2018, 38(9): 1079-.
|